Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer
Clinical trial NCT04882033 · UNKNOWN
Trial details
- NCT number
- NCT04882033
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2021-07-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.